HomeAI · summaries
Storia in 3 fonti
Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US
A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies as a potential first step to imposing restrictions. | A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies, marking a potential first step to imposing restrictions.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has
- ·
statnews.com
Bipartisan lawmakers want to require U.S. to probe reliance on foreign-made drugs, ingredients
A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too heavily on foreign countries as part of its…
